Recombinant HSV1 gG Envelope Protein (ab43048)
Key features and details
- Expression system: Escherichia coli
- Purity: > 95% SDS-PAGE
- Suitable for: ELISA, WB
Description
-
Product name
Recombinant HSV1 gG Envelope Protein -
Biological activity
Immunoreactive with sera of HSV-infected individuals, excellent antigen for detection of HSV with minimal specificity problems. -
Purity
> 95 % SDS-PAGE.
Sepharose derived purification. -
Expression system
Escherichia coli -
Protein length
Protein fragment -
Animal free
No -
Nature
Recombinant -
-
Additional sequence information
The protein contains the HSV-1 gG immunodominant regions.
-
-
Description
Recombinant HSV1 gG Envelope Protein
Specifications
Our Abpromise guarantee covers the use of ab43048 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
-
Applications
ELISA
Western blot
-
Form
Liquid -
Concentration information loading...
Preparation and Storage
-
Stability and Storage
Shipped at 4°C. Store at -20°C.
Constituents: 0.395% Tris HCl, 0.0292% EDTA, 50% Glycerol
General Info
-
Alternative names
- GG
- Glycoprotein G
- Herpes simplex virus 1 glycoprotein G
see all -
Relevance
Herpes simplex virus type 1 (HSV1) is usually associated with infections of the lips, mouth, and face. It is the most common herpes simplex virus and is usually acquired in childhood. HSV-1 often causes lesions inside the mouth such as cold sores (fever blisters) and is transmitted by contact with infected saliva. Glycoprotein G is suggested to contribute to viral entry through apical surfaces of polarized cells. -
Cellular localization
Viral envelope
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
Datasheets and documents
-
SDS download
-
Datasheet download
References (1)
ab43048 has been referenced in 1 publication.
- Awasthi S et al. Trivalent nucleoside-modified mRNA vaccine yields durable memory B cell protection against genital herpes in preclinical models. J Clin Invest 131:N/A (2021). PubMed: 34618692